Premium
Cannabidiol reverses attentional bias to cigarette cues in a human experimental model of tobacco withdrawal
Author(s) -
Hindocha Chandni,
Freeman Tom P.,
Grabski Meryem,
Stroud Jack B.,
Crudgington Holly,
Davies Alan C.,
Das Ravi K.,
Lawn William,
Morgan Celia J. A.,
Curran H. Valerie
Publication year - 2018
Publication title -
addiction
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.424
H-Index - 193
eISSN - 1360-0443
pISSN - 0965-2140
DOI - 10.1111/add.14243
Subject(s) - craving , abstinence , cannabidiol , placebo , cannabis , nicotine , psychology , attentional bias , smoking cessation , cue reactivity , medicine , audiology , clinical psychology , psychiatry , addiction , anxiety , alternative medicine , pathology
Background and Aims Cannabidiol (CBD), a non‐intoxicating cannabinoid found in cannabis, may be a promising novel smoking cessation treatment due to its anxiolytic properties, minimal side effects and research showing that it may modify drug cue salience. We used an experimental medicine approach with dependent cigarette smokers to investigate if (1) overnight nicotine abstinence, compared with satiety, will produce greater attentional bias (AB), higher pleasantness ratings of cigarette‐related stimuli and increased craving and withdrawal; and (2) CBD in comparison to placebo, would attenuate AB, pleasantness of cigarette‐related stimuli, craving and withdrawal and not produce any side effects. Design Randomized, double‐blind cross‐over study with a fixed satiated session followed by two overnight abstinent sessions. Setting UK laboratory. Participants Thirty non‐treatment‐seeking, dependent cigarette smokers recruited from the community. Intervention and comparator 800 mg oral CBD, or matched placebo (PBO) in a counterbalanced order Measurements AB to pictorial tobacco cues was recorded using a visual probe task and an explicit rating task. Withdrawal, craving, side effects, heart rate and blood pressure were assessed repeatedly. Findings When participants received PBO, tobacco abstinence increased AB ( P = 0.001, d = 0.789) compared with satiety. However, CBD reversed this effect, such that automatic AB was directed away from cigarette cues ( P = 0.007, d = 0.704) and no longer differed from satiety ( P = 0.82). Compared with PBO, CBD also reduced explicit pleasantness of cigarette images ( P = 0.011; d = 0.514). Craving (Bayes factor = 7.08) and withdrawal (Bayes factor = 6.95) were unaffected by CBD, but greater in abstinence compared with satiety. Systolic blood pressure decreased under CBD during abstinence. Conclusions A single 800‐mg oral dose of cannabidiol reduced the salience and pleasantness of cigarette cues, compared with placebo, after overnight cigarette abstinence in dependent smokers. Cannabidiol did not influence tobacco craving or withdrawal or any subjectively rated side effects.